Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

659 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
Kirkwood JM, Del Vecchio M, Weber J, Hoeller C, Grob JJ, Mohr P, Loquai C, Dutriaux C, Chiarion-Sileni V, Mackiewicz J, Rutkowski P, Arenberger P, Quereux G, Meniawy TM, Ascierto PA, Menzies AM, Durani P, Lobo M, Campigotto F, Gastman B, Long GV. Kirkwood JM, et al. Among authors: rutkowski p. Nat Med. 2024 Feb;30(2):607. doi: 10.1038/s41591-023-02661-5. Nat Med. 2024. PMID: 37923838 Free PMC article. No abstract available.
Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
Kirkwood JM, Del Vecchio M, Weber J, Hoeller C, Grob JJ, Mohr P, Loquai C, Dutriaux C, Chiarion-Sileni V, Mackiewicz J, Rutkowski P, Arenberger P, Quereux G, Meniawy TM, Ascierto PA, Menzies AM, Durani P, Lobo M, Campigotto F, Gastman B, Long GV. Kirkwood JM, et al. Among authors: rutkowski p. Nat Med. 2024 Mar;30(3):906. doi: 10.1038/s41591-023-02775-w. Nat Med. 2024. PMID: 38177857 Free PMC article. No abstract available.
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery.
Kirkwood JM, Vecchio MD, Weber J, Hoeller C, Grob JJ, Mohr P, Loquai C, Dutriaux C, Chiarion-Sileni V, Mackiewicz J, Rutkowski P, Arenberger P, Quereux G, Meniawy TM, Ascierto PA, Menzies AM, Durani P, Lobo M, Campigotto F, Gastman B, Long GV. Kirkwood JM, et al. Among authors: rutkowski p. Future Oncol. 2024 May;20(15):959-968. doi: 10.2217/fon-2023-0977. Epub 2024 Feb 23. Future Oncol. 2024. PMID: 38390818 Free article. Review.
What is the Optimal Treatment Strategy after Sarcoma R2 Surgery?
Chmiel P, Rutkowski P, Spałek M, Szumera-Ciećkiewicz A, Czarnecka AM. Chmiel P, et al. Among authors: rutkowski p. Curr Treat Options Oncol. 2024 May 29. doi: 10.1007/s11864-024-01218-z. Online ahead of print. Curr Treat Options Oncol. 2024. PMID: 38809411 Review.
Primary pelvic soft tissue sarcomas (PELVISARC): outcomes from the TransAtlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
Fiore M, Sarre-Lazcano C, Smith M, Khan M, Raut CP, Honoré C, Sargos P, Cananzi F, Grignani G, Iwata S, Gronchi A; TransAtlantic Australasian Retroperitoneal Sarcoma Working Group. Fiore M, et al. Br J Surg. 2024 May 3;111(5):znae128. doi: 10.1093/bjs/znae128. Br J Surg. 2024. PMID: 38805374 Free PMC article. No abstract available.
Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.
Lugowska I, Becker JC, Ascierto PA, Veness M, Blom A, Lebbe C, Migliano E, Hamming-Vrieze O, Goebeler M, Kneitz H, Nathan P, Rutkowski P, Slowinska M, Schadendorf D, Piulats JM, Petrelli F, van Akkooi ACJ, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Lugowska I, et al. Among authors: rutkowski p. ESMO Open. 2024 May;9(5):102977. doi: 10.1016/j.esmoop.2024.102977. Epub 2024 Apr 30. ESMO Open. 2024. PMID: 38796285 Free article. No abstract available.
Preoperative-postoperative immunotherapy as treatment of borderline resectable and oligoprogressive stage III B-D and IV melanoma.
Czarnecka AM, Ostaszewski K, Błoński P, Szumera-Ciećkiewicz A, Kozak K, Placzke J, Borkowska A, Terlecka A, Rogala P, Świtaj T, Sałamacha M, Mitręga-Korab B, Krotewicz M, Dudzisz-Śledź M, Rutkowski P. Czarnecka AM, et al. Among authors: rutkowski p. Eur J Surg Oncol. 2024 May 14;50(7):108382. doi: 10.1016/j.ejso.2024.108382. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 38763112
Establishing biomarkers for soft tissue sarcomas.
Czarnecka AM, Chmiel P, Błoński P, Rutkowski P. Czarnecka AM, et al. Among authors: rutkowski p. Expert Rev Anticancer Ther. 2024 Jun;24(6):407-421. doi: 10.1080/14737140.2024.2346187. Epub 2024 Apr 30. Expert Rev Anticancer Ther. 2024. PMID: 38682679 Review.
659 results